AP Enterprise: Church of famed revival struggles Chambersburg Public Opinion Fri, 30 Mar 2012 01:24 AM PDT PENSACOLA, Fla.â"For years starting in the mid-1990s, millions from around the globe visited a humble church in Florida s Panhandle for lively Pentecostal revival services where believers flocked on stage to be healed by God for cancer, addiction and broken hearts. | MANVILLE: Two youngsters compete in Philadelphia gym meet The Manville News Fri, 30 Mar 2012 01:16 AM PDT On Feb. 25, Brooke Hoodja competed in Philadelphia at the Pink Invitational, a meet organized to help enable Unite for HER assist women affected by breast cancer and to provide wellness education materials. | Drew softball team playing April 3 to help beat cancer Madison Eagle Fri, 30 Mar 2012 01:11 AM PDT MADISON â" The Drew University softball team will host its first annual âStrikeOut Cancer Dayâ on Tuesday, April 3, when the Lady Rangers will host the Stevens Institute of Technology team from Hoboken | Shaving heads to fund cancer research The Daily Reflector Fri, 30 Mar 2012 01:09 AM PDT East Carolina University student Sarah Swaim, 22, is a year behind in her studies due to complications from cancer treatment. She plans to be back in the classroom this summer. | March 30, 2012 Dunwoody Crier Fri, 30 Mar 2012 01:05 AM PDT The Cancer Support Community and its network of affiliates across the country have offered support, education and hope to peopl... | Free colon cancer screenings in S. Illinois WPSD Local 6 Paducah Fri, 30 Mar 2012 01:01 AM PDT Prevent colon cancer! A number of locations in Southern Illinois will be handing out free colon cancer take home tests from 11:00 a.m. to 1:00 p.m. Click on the story to see where you can get yours! | Roche to file T-DM1 breast cancer drug on good data Reuters via Yahoo! News Fri, 30 Mar 2012 00:59 AM PDT ZURICH (Reuters) - Roche said patients with an aggressive type of breast cancer lived longer after taking its experimental "armed antibody" drug without the disease worsening than those on a mix of GlaxoSmithKline drug Tykerb and Roche's Xeloda. The positive results from the first Phase III trial of the medicine - dubbed T-DM1 - clears the way for it to be submitted to European and U.S ... | | |
|